New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study reports on contributions to white matter injury in Alzheimer's disease

Study reports on contributions to white matter injury in Alzheimer's disease

by Impact Journals LLCA vicious cycle generating WM injury driven by mixed vascular and ADNC in the aging human white matter. Diagnostic challenges for IHC and neuroimaging. Credit:Aging(2
Neurology March 02,2024
Study reports on contributions to white matter injury in Alzheimer's disease

Study reports on contributions to white matter injury in Alzheimer's disease

by Impact Journals LLCA vicious cycle generating WM injury driven by mixed vascular and ADNC in the aging human white matter. Diagnostic challenges for IHC and neuroimaging. Credit:Aging(2
Neurology March 02,2024
Panel of 48 CSF proteins complements existing Alzheimer biomarkers

Panel of 48 CSF proteins complements existing Alzheimer biomarkers

by Elana GotkineA panel of 48 proteins in the cerebrospinal fluid (CSF 48 panel) complements existing CSF biomarkers for Alzheimer disease (AD), according to a study published in the Sept. 6 issue of&
Neurology March 02,2024
Panel of 48 CSF proteins complements existing Alzheimer biomarkers

Panel of 48 CSF proteins complements existing Alzheimer biomarkers

by Elana GotkineA panel of 48 proteins in the cerebrospinal fluid (CSF 48 panel) complements existing CSF biomarkers for Alzheimer disease (AD), according to a study published in the Sept. 6 issue of&
Neurology March 02,2024
New perspectives on understanding, preventing and treating vascular dementia

New perspectives on understanding, preventing and treating vascular dementia

by Hôpitaux Universitaires de GenèveCCR5 expression in response to oxidative stress is mediated by NF-κB. (A)Upper: Schematic overview of the murineCcr5gene. Blue boxes represent int
Neurology March 02,2024
New perspectives on understanding, preventing and treating vascular dementia

New perspectives on understanding, preventing and treating vascular dementia

by Hôpitaux Universitaires de GenèveCCR5 expression in response to oxidative stress is mediated by NF-κB. (A)Upper: Schematic overview of the murineCcr5gene. Blue boxes represent int
Neurology March 02,2024
Simple test could help predict risk of Alzheimer's disease 20 years in advance

Simple test could help predict risk of Alzheimer's disease 20 years in advance

by The Australian National Universitya) Sketch of protein translocation through a SiNx nanopore membrane. The proteins in a buffered electrolyte solution are placed in the cis and trans channels
Neurology March 02,2024
Simple test could help predict risk of Alzheimer's disease 20 years in advance

Simple test could help predict risk of Alzheimer's disease 20 years in advance

by The Australian National Universitya) Sketch of protein translocation through a SiNx nanopore membrane. The proteins in a buffered electrolyte solution are placed in the cis and trans channels
Neurology March 02,2024
Large amounts of sedentary time linked with higher risk of dementia in older adults, study shows

Large amounts of sedentary time linked with higher risk of dementia in older adults, study shows

by University of Southern CaliforniaCredit: CC0 Public DomainAdults aged 60 and older who spend more time engaging in sedentary behaviors like sitting while watching TV or driving may be at incre
Neurology March 02,2024
Large amounts of sedentary time linked with higher risk of dementia in older adults, study shows

Large amounts of sedentary time linked with higher risk of dementia in older adults, study shows

by University of Southern CaliforniaCredit: CC0 Public DomainAdults aged 60 and older who spend more time engaging in sedentary behaviors like sitting while watching TV or driving may be at incre
Neurology March 02,2024
Racial disparities seen in presentation of frontotemporal dementia

Racial disparities seen in presentation of frontotemporal dementia

by Elana GotkineRacial disparities can be seen in dementia severity, functional impairment, and neuropsychiatric symptoms among patients with frontotemporal dementia (FTD), according to a study publis
Neurology March 02,2024
Racial disparities seen in presentation of frontotemporal dementia

Racial disparities seen in presentation of frontotemporal dementia

by Elana GotkineRacial disparities can be seen in dementia severity, functional impairment, and neuropsychiatric symptoms among patients with frontotemporal dementia (FTD), according to a study publis
Neurology March 02,2024
Researchers create a new window on leading genetic cause of Alzheimer's

Researchers create a new window on leading genetic cause of Alzheimer's

by Pacific Northwest National LaboratoryWorkflow for molecular characterization of CSF-Lps.Lipoproteins are exchange labeled with a rhodamine-containing phospholipid and size distribution determi
Neurology March 02,2024
Researchers create a new window on leading genetic cause of Alzheimer's

Researchers create a new window on leading genetic cause of Alzheimer's

by Pacific Northwest National LaboratoryWorkflow for molecular characterization of CSF-Lps.Lipoproteins are exchange labeled with a rhodamine-containing phospholipid and size distribution determi
Neurology March 02,2024
New study reveals how biological sex influences brain proteins and disease risk

New study reveals how biological sex influences brain proteins and disease risk

by Emory UniversitySummary of main analyses. Credit:Nature Medicine(2023). DOI:10.1038/s41591-023-02509-yAn Emory led study published inNature MedicineandSynapse&nbs
Neurology March 02,2024
New study reveals how biological sex influences brain proteins and disease risk

New study reveals how biological sex influences brain proteins and disease risk

by Emory UniversitySummary of main analyses. Credit:Nature Medicine(2023). DOI:10.1038/s41591-023-02509-yAn Emory led study published inNature MedicineandSynapse&nbs
Neurology March 02,2024
Smarter CT scans may approach the level of MRI and support dementia diagnosis

Smarter CT scans may approach the level of MRI and support dementia diagnosis

by Margareta G. Kubista,Swedish Research CouncilImaging-based volumetric measures. The CT-based GM, WM, CSF, ICV and VCSF maps were automatically segmented using deep-learning techniques. Credit
Neurology March 02,2024
Smarter CT scans may approach the level of MRI and support dementia diagnosis

Smarter CT scans may approach the level of MRI and support dementia diagnosis

by Margareta G. Kubista,Swedish Research CouncilImaging-based volumetric measures. The CT-based GM, WM, CSF, ICV and VCSF maps were automatically segmented using deep-learning techniques. Credit
Neurology March 02,2024
Novel tau PET tracer exhibits high sensitivity and specificity, allows earlier identification of Alzheimer's disease

Novel tau PET tracer exhibits high sensitivity and specificity, allows earlier identification of Alzheimer's disease

by Society of Nuclear MedicineTau immunohistochemistry and in vitro autoradiograms of18F-SNFT-1,18F-MK-6240,18F-PM-PBB3, and18F-flortaucipir in medial temporal sections fr
Neurology March 02,2024
Novel tau PET tracer exhibits high sensitivity and specificity, allows earlier identification of Alzheimer's disease

Novel tau PET tracer exhibits high sensitivity and specificity, allows earlier identification of Alzheimer's disease

by Society of Nuclear MedicineTau immunohistochemistry and in vitro autoradiograms of18F-SNFT-1,18F-MK-6240,18F-PM-PBB3, and18F-flortaucipir in medial temporal sections fr
Neurology March 02,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com